Dalbavancin compositions for treatment of bacterial infections
US7119061B2 · kind B2 · utility
4Cited by
25References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Apr 27, 2004 |
| Grant date | Oct 10, 2006 |
| Priority date | — |
| Expiry date | Apr 27, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin formulations for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.